Skip to content

Main Navigation

The Vaccine Confidence Project
  • Home
  • Our Work
    • All work
    • Projects
    • Publications
    • Reports
    • Briefings & Guidance
    • Data Visualisations
  • Index
    • Vaccine Confidence Index Map
    • Data & Methodolgy
  • About
    • Who We Are
    • Theory of Change
    • Strategy
    • Partnerships
    • The Team
    • FAQ
  • News
    • Latest News
    • Media & Commentary
    • Video & Events
    • Podcasts
  • Get Involved
  • For Media
  • Contact Us
  • All work
  • Projects
  • Publications
  • Reports
  • Briefings & Guidance
  • Data Visualisations

Risk perceptions and acceptance of COVID-19 and influenza vaccines in Europe

Vaccine Confidence Project logo
GlaxoSmithKline logo

Overview

The purpose of this study is to explore what are the psychosocial factors influencing confidence in and acceptance of COVID-19 vaccination and how this compares with other adult vaccines such as influenza vaccination. The objectives will be to:

Primary Objectives

  1. To conduct an in-depth investigation of the psychosocial influences on COVID-19 vaccine confidence.
  2. To explore risk perceptions of other vaccine preventable diseases and adult vaccines and how these perceptions have changed as a result of the COVID-19 pandemic.

Key Secondary Objectives

  1. To explore the influence of trust in vaccines, vaccine policies, processes, and providers on COVID-19 and influenza vaccine acceptance.
  2. To identify social and emotional determinants of health associated with COVID-19 and influenza vaccination views.

This study will use a mixed-methods approach, with study data collected via a combination of quantitative surveys and qualitative in-depth interviews, to gain a deeper understanding of people’s confidence in and acceptance of COVID-19 vaccination and how this compares with other adult vaccines. The study population consists of nationally representative samples of adults (≥ 18 years of age) in three European countries (France, Hungary and Italy).

Related content

Projects
Mapping Public Sentiments and Emotions around COVID-19 prevention and control measures

Project to support the development of guidance on interventions to improve vaccine uptake in LMICs, informed by an assessment of local barriers and drivers to adult vaccine uptake.

Projects
State of Vaccine Confidence in the EU

In 2018, the European Commission engaged the Vaccine Confidence Project to create the first “State of Vaccine Confidence in the EU” report. Since then, the VCP has conducted bi-annual research to map and monitor public attitudes to vaccines across the region and examine trends over time.

Projects
Public Perceptions and Uptake of the COVID-19 vaccine in Asia-Pacific countries

To identify knowledge gaps, beliefs and attitudes in relation to the COVID-19 pandemic and COVID-19 vaccine acceptance among adults in the Asia-Pacific region, the Vaccine Confidence Project conducted two waves of quantitative research in 2021 and 2022.

Projects
Global Attitudes Toward Maternal Vaccination

Maternal vaccination offers the potential to tackle the sustainable development goal 3 (SDG3) to reduce neonatal and maternal vaccination globally.

Projects
National Institute for Health Research (NIHR) Health Protection Research Unit in Vaccines and Immunisation

Our research aims to reverse the decline in immunisation coverage in children, increase vaccine uptake in adults and reduce inequalities in the vaccine service.

country
Nigeria

Vaccine confidence in Nigeria is high compared to other countries. The latest data we have for Nigeria is from surveys conducted in 2022 which showed that 81% of people feel that vaccines are safe and 82% think they are effective. 81% of those surveyed said they believe it’s important for children to have vaccines and 78% feel that vaccines are compatible with their religious beliefs.

Summary

Project date:

2023

Countries:
  • France
  • Italy
  • Hungary
Topics:
  • Region - Europe
  • COVID-19
  • Influenza
  • Social, Structural and Emotional Determinants of Health
  • Risk
  • Qualitative Research
  • Quantitative Research
Team leads
  • Dr. Emilie Karafillakis
Key partners
  • GlaxoSmithKline

Latest content

Publications
A vaccine chatbot intervention for parents to improve HPV vaccination uptake among middle school girls: a cluster randomized trial

This study assesses the effectiveness of a vaccine chatbot in improving human papillomavirus (HPV) vaccination among female middle school students aged 12–15 years across diverse socioeconomic settings in China, where HPV vaccination is primarily paid out-of-pocket.

Publications
Mapping global public perspectives on mRNA vaccines and therapeutics

We conducted a social listening analysis to assess attitudes towards mRNA vaccines and therapeutics on Twitter from June 2022 to May 2023. Our findings reveal widespread negative sentiment and a global lack of confidence in mRNA vaccines and therapeutics, with frequent discussions of severe vaccine side effects, rumors, and misinformation.

Data Visualisations
Mapping global public perspectives on Health AI

We conducted a social listening analysis to assess attitudes towards Health AI.

Regional offices:
Quick Links
  • Who we are
  • Our work
  • News
  • Partnerships
  • Privacy Policy & Cookies
  • Terms of Use
  • Image credits
Get in touch
  • Contact Us
  • Partnerships
Follow us
Subscribe
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}